28 Nov 20241cites
Immunohistochemical Expression of ROR2 in Gastrointestinal Stromal TumorPublisher siteJournal of Gastrointestinal Cancer, Gastrointestinal Tumor Research and Treatment
Active, last published 2026
In cell adhesion molecules research
Mona
Kandil
Scholar“Research focused on Cell Adhesion Molecules Research and adjacent fields.”
Menoufia University
Egypt
Claim Your ProfileEgypt11
H-index
377
Citations
Mona has not officially claimed their profile. If you are Mona, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
Expert
UPGRADE
01 · About the work
What I study
ona Kandil is a researcher working on Cell Adhesion Molecules Research. A fuller summary will appear once they update their profile.
02 · Reach
Publication output and reach
Mona's work has been cited 377 times across 1 active year. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
03 · Research focus
Topics
Cell Adhesion Molecules Research×3Breast Cancer Treatment Studies×2Lymphoma Diagnosis and Treatment×2Sarcoma Diagnosis and Treatment×2Cancer Cells and Metastasis×2
04 · Where I am
Affiliations
Affiliation on published researchMenoufia University, EgyptDrawn from the institution listed on this researcher’s published work.
Research themes (UN SDGs)
05 · Selected work
Recent publications
2 works1 May 2024Open access1cites
Does Autophagy have a Role in the Pathogenesis of Pediatric Hepatic Steatosis?Publisher siteAsian Pacific Journal of Cancer Prevention, Liver Disease Diagnosis and Treatment
Expert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Are you Mona?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
Free to claim · takes a minute to verify it’s you